229 related articles for article (PubMed ID: 12941819)
1. SERPINE2 (protease nexin I) promotes extracellular matrix production and local invasion of pancreatic tumors in vivo.
Buchholz M; Biebl A; Neesse A; Wagner M; Iwamura T; Leder G; Adler G; Gress TM
Cancer Res; 2003 Aug; 63(16):4945-51. PubMed ID: 12941819
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic stellate cells potentiate proinvasive effects of SERPINE2 expression in pancreatic cancer xenograft tumors.
Neesse A; Wagner M; Ellenrieder V; Bachem M; Gress TM; Buchholz M
Pancreatology; 2007; 7(4):380-5. PubMed ID: 17703087
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator and serine protease inhibitor-E2 (protease nexin-1) expression by bovine granulosa cells in vitro.
Cao M; Sahmi M; Lussier JG; Price CA
Biol Reprod; 2004 Sep; 71(3):887-93. PubMed ID: 15128599
[TBL] [Abstract][Full Text] [Related]
4. The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro.
Paciucci R; Torà M; Díaz VM; Real FX
Oncogene; 1998 Feb; 16(5):625-33. PubMed ID: 9482108
[TBL] [Abstract][Full Text] [Related]
5. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
Fujisawa T; Joshi B; Nakajima A; Puri RK
Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma.
Linder S; Castaños-Velez E; von Rosen A; Biberfeld P
Hepatogastroenterology; 2001; 48(41):1321-7. PubMed ID: 11677955
[TBL] [Abstract][Full Text] [Related]
7. Extracellular matrix components regulating glandular differentiation and the formation of basal lamina of a human pancreatic cancer cell line in vitro.
Yamanari H; Suganuma T; Iwamura T; Kitamura N; Taniguchi S; Setoguchi T
Exp Cell Res; 1994 Apr; 211(2):175-82. PubMed ID: 8143763
[TBL] [Abstract][Full Text] [Related]
8. Role of fibrillar Tenascin-C in metastatic pancreatic cancer.
Chen J; Chen Z; Chen M; Li D; Li Z; Xiong Y; Dong J; Li X
Int J Oncol; 2009 Apr; 34(4):1029-36. PubMed ID: 19287959
[TBL] [Abstract][Full Text] [Related]
9. Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin.
Johnson SK; Ramani VC; Hennings L; Haun RS
Cancer; 2007 May; 109(9):1811-20. PubMed ID: 17354228
[TBL] [Abstract][Full Text] [Related]
10. RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells.
Tsutsumida H; Swanson BJ; Singh PK; Caffrey TC; Kitajima S; Goto M; Yonezawa S; Hollingsworth MA
Clin Cancer Res; 2006 May; 12(10):2976-87. PubMed ID: 16707592
[TBL] [Abstract][Full Text] [Related]
11. Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell lines.
Koo TH; Lee JJ; Kim EM; Kim KW; Kim HD; Lee JH
Oncogene; 2002 Jun; 21(26):4080-8. PubMed ID: 12037664
[TBL] [Abstract][Full Text] [Related]
12. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK
Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026
[TBL] [Abstract][Full Text] [Related]
13. Expression of tissue factor pathway inhibitor 2 in human pancreatic carcinoma and its effect on tumor growth, invasion, and migration in vitro and in vivo.
Tang Z; Geng G; Huang Q; Xu G; Hu H; Chen J; Li J
J Surg Res; 2011 May; 167(1):62-9. PubMed ID: 20018303
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of integrins by interleukin-1alpha, and their relationship with metastatic and invasive behavior of human pancreatic ductal adenocarcinoma cells.
Sawai H; Takeyama H; Yamamoto M; Furuta A; Funahashi H; Okada Y; Sato M; Tanaka M; Manabe T
J Surg Oncol; 2003 Jan; 82(1):51-6. PubMed ID: 12501168
[TBL] [Abstract][Full Text] [Related]
15. Action of antiproteases on pancreatic cancer cells.
Uchima Y; Sawada T; Hirakawa K
JOP; 2007 Jul; 8(4 Suppl):479-87. PubMed ID: 17625304
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor activator inhibitor type 1 suppresses metastatic pulmonary colonization of pancreatic carcinoma cells.
Fukushima T; Kawaguchi M; Yamasaki M; Tanaka H; Yorita K; Kataoka H
Cancer Sci; 2011 Feb; 102(2):407-13. PubMed ID: 21166957
[TBL] [Abstract][Full Text] [Related]
17. Inserting chromosome 18 into pancreatic cancer cells switches them to a dormant metastatic phenotype.
Lefter LP; Sunamura M; Furukawa T; Takeda K; Kotobuki N; Oshimura M; Matsuno S; Horii A
Clin Cancer Res; 2003 Oct; 9(13):5044-52. PubMed ID: 14581380
[TBL] [Abstract][Full Text] [Related]
18. TIMP-1 antisense gene transfection attenuates the invasive potential of pancreatic cancer cells in vitro and inhibits tumor growth in vivo.
Bloomston M; Shafii A; Zervos E; Rosemurgy AS
Am J Surg; 2005 Jun; 189(6):675-9. PubMed ID: 15910719
[TBL] [Abstract][Full Text] [Related]
19. Protein C and its inhibitor in malignancy.
Suzuki K; Hayashi T
Semin Thromb Hemost; 2007 Oct; 33(7):667-72. PubMed ID: 18000793
[TBL] [Abstract][Full Text] [Related]
20. Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line.
Kohlgraf KG; Gawron AJ; Higashi M; Meza JL; Burdick MD; Kitajima S; Kelly DL; Caffrey TC; Hollingsworth MA
Cancer Res; 2003 Aug; 63(16):5011-20. PubMed ID: 12941828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
